Characteristics | All patients N = 119 | Center 1 (cisatracurium use) N = 97 | Center 2 (atracurium use) N = 22 |
---|---|---|---|
Age (years) | 62 (52–73) | 62 (51–72) | 63 (52–73) |
Male [n (%)] | 78 (66) | 61 (63) | 17 (77) |
Body mass index (kg/m2) | 25.5 (23.4–29.6) | 25.3 (23.1–29.6) | 26.6 (23.7–32.2) |
SAPS II (points) | 51 (40–62) | 50 (40–62) | 51 (44–60) |
SOFA (points) | 9 (6–12) | 9 (7–12) | 9 (6–12) |
Length of stay before ICU (days) | 1 (0–4) | 1 (0–4) | 1 (0–3) |
Main reason for ICU admission [n (%)] | |||
Medical | 111 (93) | 93 (96) | 18 (82)* |
Surgical | 8 (7) | 4 (4) | 4 (18) |
Main reason for neuromuscular blockade [n (%)] | |||
ARDS | 94 (79) | 78 (80) | 16 (73)* |
Exacerbations of COPD | 7 (6) | 5 (5) | 2 (9) |
Status asthmaticus | 3 (3) | 3 (3) | 0 |
Other respiratory failures | 6 (5) | 5 (5) | 1 (4.5) |
Abdominal compartment syndromes | 5 (4) | 2 (2) | 3 (13.5) |
Miscellaneous | 4 (3) | 4 (4) | 0 |
Main comorbidities [n (%)] | |||
Diabetes | 16 (13) | 14 (14) | 2 (9) |
Renal disease | 8 (7) | 7 (7) | 1 (5) |
Cirrhosis | 16 (13) | 14 (14) | 2 (9) |
Corticosteroid treatment | 12 (10) | 11 (11) | 1 (5) |
Sepsis [n (%)] | 85 (71) | 68 (70) | 17 (77) |
Catecholamines [n (%)] | 78 (66) | 62 (64) | 16 (73) |
Renal replacement therapy [n (%)] | 9 (8) | 6 (6) | 3 (14) |